CTNNB1 and neoplasm: For the study of ACP, in addition to CTNNB1 mutation expressing β-catenin to activate the classical Wnt signaling pathway and promote the proliferation and migration of tumor cells, current studies have confirmed that SHH in ACP can also participate in the regulation of the Wnt signaling pathway by promoting the expression of β-catenin through autocrine or paracrine.